Advances in understanding pulmonary host defense mechanisms

Dendritic cell function and immunomodulation

Herbert Reynolds, J. Lloyd Huck

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Mucosal host immunity in the respiratory tract can probably be manipulated to better improve defense against microbes and other antigens or particulates that cause infection and respiratory illness. An evolving strategy is to target the extensive network of dendritic cells in the lungs, especially dendritic cells located in the airway epithelium, which are super antigen-presenting cells that can initiate specific T-lymphocyte immune responses. Also, dendritic cells can elaborate cytokines such as interleukin 1 2 which drive other components of the immune response including antibody production. However, dendritic cells can be counter-regulated by inhibitory cytokines or certain microbes that create a dynamic interplay. This review emphasizes human studies and relevant animal models that provide a framework for future planning of experimental approaches to enhancing antimicrobial immunity and respiratory host defense. (C) 2000 Lippincott Williams and Wilkins, Inc.

Original languageEnglish (US)
Pages (from-to)209-216
Number of pages8
JournalCurrent Opinion in Pulmonary Medicine
Volume6
Issue number3
DOIs
StatePublished - Jan 1 2000

Fingerprint

Immunomodulation
Dendritic Cells
Lung
Cytokines
Mucosal Immunity
Antigen-Presenting Cells
Interleukin-1
Respiratory Tract Infections
Respiratory System
Antibody Formation
Interleukin-2
Immunity
Epithelium
Animal Models
T-Lymphocytes
Antigens

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

@article{202062cac3784f2187785a11ccefbba7,
title = "Advances in understanding pulmonary host defense mechanisms: Dendritic cell function and immunomodulation",
abstract = "Mucosal host immunity in the respiratory tract can probably be manipulated to better improve defense against microbes and other antigens or particulates that cause infection and respiratory illness. An evolving strategy is to target the extensive network of dendritic cells in the lungs, especially dendritic cells located in the airway epithelium, which are super antigen-presenting cells that can initiate specific T-lymphocyte immune responses. Also, dendritic cells can elaborate cytokines such as interleukin 1 2 which drive other components of the immune response including antibody production. However, dendritic cells can be counter-regulated by inhibitory cytokines or certain microbes that create a dynamic interplay. This review emphasizes human studies and relevant animal models that provide a framework for future planning of experimental approaches to enhancing antimicrobial immunity and respiratory host defense. (C) 2000 Lippincott Williams and Wilkins, Inc.",
author = "Herbert Reynolds and Huck, {J. Lloyd}",
year = "2000",
month = "1",
day = "1",
doi = "10.1097/00063198-200005000-00008",
language = "English (US)",
volume = "6",
pages = "209--216",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Advances in understanding pulmonary host defense mechanisms : Dendritic cell function and immunomodulation. / Reynolds, Herbert; Huck, J. Lloyd.

In: Current Opinion in Pulmonary Medicine, Vol. 6, No. 3, 01.01.2000, p. 209-216.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Advances in understanding pulmonary host defense mechanisms

T2 - Dendritic cell function and immunomodulation

AU - Reynolds, Herbert

AU - Huck, J. Lloyd

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Mucosal host immunity in the respiratory tract can probably be manipulated to better improve defense against microbes and other antigens or particulates that cause infection and respiratory illness. An evolving strategy is to target the extensive network of dendritic cells in the lungs, especially dendritic cells located in the airway epithelium, which are super antigen-presenting cells that can initiate specific T-lymphocyte immune responses. Also, dendritic cells can elaborate cytokines such as interleukin 1 2 which drive other components of the immune response including antibody production. However, dendritic cells can be counter-regulated by inhibitory cytokines or certain microbes that create a dynamic interplay. This review emphasizes human studies and relevant animal models that provide a framework for future planning of experimental approaches to enhancing antimicrobial immunity and respiratory host defense. (C) 2000 Lippincott Williams and Wilkins, Inc.

AB - Mucosal host immunity in the respiratory tract can probably be manipulated to better improve defense against microbes and other antigens or particulates that cause infection and respiratory illness. An evolving strategy is to target the extensive network of dendritic cells in the lungs, especially dendritic cells located in the airway epithelium, which are super antigen-presenting cells that can initiate specific T-lymphocyte immune responses. Also, dendritic cells can elaborate cytokines such as interleukin 1 2 which drive other components of the immune response including antibody production. However, dendritic cells can be counter-regulated by inhibitory cytokines or certain microbes that create a dynamic interplay. This review emphasizes human studies and relevant animal models that provide a framework for future planning of experimental approaches to enhancing antimicrobial immunity and respiratory host defense. (C) 2000 Lippincott Williams and Wilkins, Inc.

UR - http://www.scopus.com/inward/record.url?scp=0033943385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033943385&partnerID=8YFLogxK

U2 - 10.1097/00063198-200005000-00008

DO - 10.1097/00063198-200005000-00008

M3 - Review article

VL - 6

SP - 209

EP - 216

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 3

ER -